Should you buy these stocks too? What would it take to make you feel wealthy? Join the NASDAQ Community today and get free, instant access to portfolios, stock ratings, real-time alerts, and more! For the details of EagleClaw Capital Managment, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=EagleClaw+Capital+Managment%2C+LLC EagleClaw Capital Managment, LLC initiated holdings in Silver Wheaton Corp. The purchase prices were between $17.04 and $26.27, with an estimated average price of $20.85. The stock is now traded at around $22.29. The impact to the portfolio due to this purchase was 1.06%. The holdings were 86,650 shares as of 2016-12-31. EagleClaw Capital Managment, LLC initiated holdings in Magellan Midstream Partners LP. The purchase prices were between $65.17 and $75.79, with an estimated average price of $70.03. The stock is now traded at around $79.35. The impact to the portfolio due to this purchase was 0.13%. The holdings were 2,800 shares as of 2016-12-31. EagleClaw Capital Managment, LLC initiated holdings in Vanguard Total Stock Market. The purchase prices were between $106.79 and $117.53, with an estimated average price of $112.57. The stock is now traded at around $119.54. The impact to the portfolio due to this purchase was 0.13%. The holdings were 1,780 shares as of 2016-12-31. EagleClaw Capital Managment, LLC sold out the holdings in Amgen Inc. The sale prices were between $135.22 and $168.31, with an estimated average price of $150.5. EagleClaw Capital Managment, LLC sold out the holdings in Genomic Health Inc. The sale prices were between $28.41 and $33.59, with an estimated average price of $30.49. EagleClaw Capital Managment, LLC sold out the holdings in Philip Morris International Inc. The sale prices were between $87.33 and $97.86, with an estimated average price of $92.66. EagleClaw Capital Managment, LLC sold out the holdings in AdvanSix Inc. The sale prices were between $14.01 and $22.97, with an estimated average price of $17.96. This article first appeared on GuruFocus . The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages. You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings? Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.